Illumina Ventures raises $230m

The US venture capital firm closes inaugural fund above target.

Illumina Innovation Fund I has held a final close at $230 million, surpassing its initial target of $200 million. The firm’s debut vehicle focuses exclusively on genomics and precision medicine.